Abstract:Objective:To compare the serum levels of transforming growth factor-β1 (TGF-β1),interleukin-17 (IL-17),inter-leukin-23 (IL-23)in patients with bronchial asthma at different degrees of airway obstruction after standardized treatment,in order to explore the significance of TGF-β1,IL-17,IL-23 in airway remodeling in patients with asthma.Methods:Ninety-one asthma patients,who underwent standardized treatment for at least three months,were recruited by applying control study.By using FEV1%pred as grouping criterion,the 91 patients with asthma were divided into the mild asthma group (FEV1%pred≥80%),the moderate asthma group (60 %< FEV1 %< 80%)and the severe asthma group (FEV1 %≤60%).In addition, 27 healthy people were selected as control group.The serum levels of TGF-β1,IL-17,and IL-23 in each group were monitored and compared with each other.Results:1.Compared with that in the control group,the serum levels of TGF-β1 in asthma group were higher,while the levels of IL-17 were lower.There was no significant difference in serum IL-23 level between the two groups.2.Comparison were done among the asthma groups.There were significant differences in serum levels of TGF-β1 and IL-17 between mild asthma group and moderate-to-severe asthma group (P < 0.05 ),while there were no significant differences between moderate group and severe group.3.Serum IL-17 level was correlated negatively with TGF-β1 level. FEV1%pred was correlated negatively with serum TGF-β1 level and positively with serum IL-17 level,while it had no correla-tion with serum IL-23 level.Conclusions:In patients with asthma,the serum TGF-β1 level is negatively correlated with FEV1%pred,which indicates that TGF-β1 is an important index for airway remodeling.The serum levels of IL-17 in patients with asthma is lower than those in healthy people.Furthermore,the decrease of serum IL-17 level is more significant while the obstruction is worse.The probable answer is that persistent airway inflammation inhibits secretion and expression of IL-17,so that the expression of IL-17 declines in phase with severe impairment of pulmonary function and severe airway remodeling.

Research progress of JAK/STAT6 signal transduction of bronchial asthma

Functions of Signal Transducer and Activator of Transcription 6 and Effects of Peroxisome Proliferator-Activated Receptor-Γ and Glucocorticoid on Bronchial Asthma

Fas/FasL and Bronchial Asthma

Il4 And Il-17a Provide A Th2/Th17-Polarized Inflammatory Milieu In Favor Of Tgf-Beta 1 To Induce Bronchial Epithelial-Mesenchymal Transition (Emt)

The IL6R Gene Polymorphisms Are Associated with Sil-6R, IgE and Lung Function in Chinese Patients with Asthma.

Consistent Biomarkers And Related Pathogenesis Underlying Asthma Revealed By Systems Biology Approach

Influence of Kechuan Acupoint Application on the Expression of JAK1 and STAT6 in Lung Tissue of Asthmatic Rats

Recent Advance in Regulatory T Cells and Bronchial Asthma

IL-1β: a Key Modulator in Asthmatic Airway Smooth Muscle Hyper-Reactivity

An Alternate STAT6-independent Pathway Promotes Eosinophil Influx into Blood During Allergic Airway Inflammation.

IL-1 beta: a key modulator in asthmatic airway smooth muscle hyper-reactivity

T-helper cells and their cytokines in pathogenesis and treatment of asthma

Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma

Epithelial SIRT6 governs IL-17A pathogenicity and drives allergic airway inflammation and remodeling

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

Research Progresses on the Correlation Between IL-12 Expression Deficiency and Bronchial Asthma

The Transcription Levels of Linker for Activation of T Cell and Its Upstream Regulatory Factors in T Cells of Asthmatic Patients

Detection and Significance of Serum Th17 Cell Related Cytokines in Patients with Bronchial Asthma

Identification of miRNA–mRNA–TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches

Mechanistic analysis of Th2-type inflammatory factors in asthma

Advance on Studies of T Helper 17 Cells and Its Relative Cytokines and Bronchial Asthma